Alivecor

AliveCor is a digital health company specializing in AI-enabled cardiac monitoring solutions through portable ECG devices. The company serves over 3 million lifetime users across 40+ countries with FDA-cleared personal ECG devices including the Kardia 12L (first portable 12-lead ECG), KardiaMobile 6L, and K1000 InstantQT. Their technology is backed by over 200 clinical publications.

The company offers comprehensive software platforms including KardiaPro for healthcare professionals, KardiaStation for enterprise deployment, and KardiaComplete for payers and employers. Their solutions integrate AI-driven analysis algorithms that provide real-time heart rhythm data and seamlessly connect to existing clinical workflows. AliveCor serves multiple market segments including health systems, biopharma for clinical trials, employers, payers, and direct-to-consumer.

Led by CEO Priya Abani (formerly Amazon Alexa Voice Service GM), AliveCor has established strategic partnerships with major healthcare organizations including Cleveland Clinic, Veterans Affairs, Omron Healthcare, and GE Healthcare. The company specializes in decentralized clinical trials with remote cardiac safety monitoring and offers PEPM (per-employee-per-month) cardiac health solutions for enterprise customers.

Choose AliveCor when you need clinically validated, portable cardiac monitoring solutions with strong AI diagnostic capabilities. Their devices and platforms excel in scenarios requiring remote ECG collection, whether for clinical trials, enterprise cardiac health programs, or point-of-care diagnostics in resource-limited settings.

Expect a comprehensive ecosystem approach combining FDA-cleared hardware, AI-powered analysis software, and professional services. Their solutions are particularly strong for organizations seeking to reduce in-clinic visits for cardiac monitoring while maintaining diagnostic quality, with proven integration capabilities for existing healthcare workflows.

AliveCor operates exclusively in healthcare with specialized focus on cardiovascular care. The company serves cardiology practices, health systems, pharmaceutical companies conducting cardiac safety trials, Veterans Affairs facilities, and payers managing heart disease populations. Their solutions address HIPAA compliance requirements with BAA availability and FDA clearance for diagnostic claims.

The company demonstrates deep healthcare domain expertise through partnerships with Cleveland Clinic for AI development, extensive clinical research validation, and purpose-built platforms for both enterprise healthcare providers (KardiaPro) and decentralized clinical trial applications with validated QT monitoring protocols.

Health systems and cardiology practices implementing remote monitoring programs, pharmaceutical companies conducting cardiac safety trials, and large employers or payers seeking to manage cardiovascular disease costs through PEPM solutions. Organizations requiring FDA-cleared diagnostic tools with extensive clinical evidence and those comfortable with technology-enabled care delivery models will achieve the strongest results.